BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7885064)

  • 1. Distribution and lytic activity of NK cell subsets in the elderly.
    Mariani E; Monaco MC; Cattini L; Sinoppi M; Facchini A
    Mech Ageing Dev; 1994 Oct; 76(2-3):177-87. PubMed ID: 7885064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
    Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aging on distribution and functional activity of GL183+ and EB6+ NK cells.
    Mariani E; Gemma Monaco MC; Cattini L; De Zwart JF; Tripodi G; Orengo A; Facchini A
    Arch Gerontol Geriatr; 1992; 15 Suppl 1():249-56. PubMed ID: 18647694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions.
    Cauda R; Goletti D; Lucia MB; Tumbarello M; Rumi C; Orengo AM; Moretta A
    Clin Immunol Immunopathol; 1994 Mar; 70(3):198-205. PubMed ID: 8313656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
    Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M
    Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
    Fuchshuber PR; Lotzová E
    Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
    J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.
    Moretta A; Bottino C; Tripodi G; Vitale M; Pende D; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Millo R
    Int J Cancer Suppl; 1992; 7():6-10. PubMed ID: 1428407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
    Lebow LT; Jewett A; Bonavida B
    J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism.
    Vitale M; Zamai L; Neri LM; Galanzi A; Facchini A; Rana R; Cataldi A; Papa S
    Cell Immunol; 1992 Nov; 145(1):1-10. PubMed ID: 1423637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin.
    Orago AS; Facer CA
    Clin Exp Immunol; 1991 Oct; 86(1):22-9. PubMed ID: 1833100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A; Lanier LL; Cwirla S; Phillips JH
    J Immunol; 1989 Nov; 143(10):3183-91. PubMed ID: 2530273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets.
    Carver FM; Thomas JM
    Cell Immunol; 1988 Nov; 117(1):56-69. PubMed ID: 2902933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
    J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.